This year, Xstrahl marks its 10 year anniversary of advanced radiation research thanks to the Small Animal Radiation Research Platform (SARRP). See the wide range of research capabilities that SARRP has to offer.
CIX3 used in HER2-positive Tumor Research
See what researchers found in the recent study: Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2‑positive murine tumor. See the original publication here.
